- CBG
Dutch National Competent Authority (English: MEB). http://www.cbg-meb.nl/"
- CEESP
French Health Technology Assessment body. http://www.has-sante.fr/portail/jcms/c_419565/fr/commission-evaluation-economique-et-de-sante-publique"
- Clinical Trial Application
Clinical Trial Application
- Clinical trial authorisation
Before a clinical trial can start, the sponsor must apply for and be given clinical trial authorisation (CTA). Each European country has its own regulatory authority that assesses applications for clinical trial authorisations. For clinical trials that will take place in more than one European(...)
- Clinician-reported outcome
A type of outcome assessment determined by a trained health-care professional after observation of a patient’s health condition.
- ClinRO
A type of outcome assessment determined by a trained health-care professional after observation of a patient’s health condition.
- Cohort Studies
Cohort studies are used to study how common diseases are, their causes, and their prognoses. Cohorts are groups of people who are selected on the basis of certain characteristics. For example, if exposure to a risk factor such as cigarette smoke is suspected to cause a disease, a cohort can be(...)
- Cold-chain
An uninterrupted series of production, storage, and distribution activities, along with associated equipment and logistics, which maintain a desired low temperature range. It is necessary to maintain the quality and efficacy of certain medicines and vaccines.
- College ter Beoordeling van Geneesmiddelen
Dutch National Competent Authority (English: MEB). http://www.cbg-meb.nl/"
- Combined advanced-therapy medicines
Combined advanced-therapy medicines are medical products based on the combination of genes (gene therapy), cell therapy (cell therapy) or tissues (tissue engineering) with one or more medical devices as an integral part of the medicine.
- Commissie Tegemoetkoming Geneesmiddelen
Belgian Health Technology Assessment body. http://www.riziv.fgov.be/nl/riziv/organen/Paginas/commissie-tegemoetkoming-geneesmiddelen.aspx#.V1rMphM4ViQ"
- Commission de Remboursement des Médicaments
Belgian commission for reimbursement of medicines. http://www.inami.fgov.be/fr/inami/organes/Pages/commission-remboursement-m%C3%A9dicaments.aspx#.V16FmNKLRD8"
- Commission évaluation économique et de santé publique
French Health Technology Assessment body. http://www.has-sante.fr/portail/jcms/c_419565/fr/commission-evaluation-economique-et-de-sante-publique"
- CRM
Belgian commission for reimbursement of medicines. http://www.inami.fgov.be/fr/inami/organes/Pages/commission-remboursement-m%C3%A9dicaments.aspx#.V16FmNKLRD8"
- CTA
Before a clinical trial can start, the sponsor must apply for and be given clinical trial authorisation (CTA). Each European country has its own regulatory authority that assesses applications for clinical trial authorisations. For clinical trials that will take place in more than one European(...)
- CTG
Belgian Health Technology Assessment body. http://www.riziv.fgov.be/nl/riziv/organen/Paginas/commissie-tegemoetkoming-geneesmiddelen.aspx#.V1rMphM4ViQ"
